Prescient Therapeutics Ltd PTX.AX
AUD0.07 AUD0.00 (1.56%) 1D
Last Updated: Oct 14, 12:00 AM·ASX
Pricing for AU stocks is delayed by 24 hours
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
News
Pricing
Company
About Musaffa
Investors
Build with us
Is Prescient Therapeutics Ltd Stock Halal?
Shariah Compliance Analysis of PTX.AX Stock
Australia Health Care Micro Cap No. As of October 2026, Prescient Therapeutics Ltd (PTX.AX) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Prescient Therapeutics Ltd does not pass Musaffa's business and financial screening criteria.
Prescient Therapeutics Ltd. is a biopharmaceutical company, which engages in the discovery and development of novel immunotherapeutic products for the treatment of chronic infectious diseases and cancer. The company is headquartered in Melbourne, Victoria. The company is engaged in developing personalized medicine approaches to cancer, including targeted and cellular therapies. Its product pipeline includes PTX-100, CellPryme-M, and OmniCAR. PTX-100 is a first-in-class targeted therapy which can disrupt the RAS family pathway by inhibiting the prenylation action of the enzyme GGT-1. PTX-100 is in a Phase 2a clinical study in refractory/relapsed Cutaneous T Cell Lymphoma with Fast Track Designation. CellPryme-M is a high-performance cell therapy enhancement platform that can improve CAR-T efficacy. The CellPryme platform consists of two distinct components which can be used separately but have significant synergies when used together. OmniCAR is a universal CAR platform that is controllable, with plug and play capabilities to enable a wider range of cancers to be targeted. OmniCAR enables controllable T-cell activity and multiantigen targeting with a single cell product.
PTX.AX Shariah Compliance
Screening Methodology: AAOIFI
As of October 2026, Prescient Therapeutics Ltd is classified as not halal.
NOT HALALPrescient Therapeutics Ltd (PTX.AX) Chart
Fetching Price Chart...
Financial Metrics & Statements of Prescient Therapeutics Ltd (PTX.AX)
FAQ's for Prescient Therapeutics Ltd (PTX.AX)
- As of October 2026, Prescient Therapeutics Ltd PTX.AX is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Prescient Therapeutics Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Prescient Therapeutics Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Prescient Therapeutics Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Prescient Therapeutics Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Prescient Therapeutics Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Prescient Therapeutics Ltd (PTX.AX)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
